Dami A. Collier

6.6k total citations
20 papers, 749 citations indexed

About

Dami A. Collier is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Dami A. Collier has authored 20 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Dami A. Collier's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (5 papers). Dami A. Collier is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (5 papers). Dami A. Collier collaborates with scholars based in United Kingdom, South Africa and France. Dami A. Collier's co-authors include Robert Kerwin, David Ball, G.W. Roberts, Monsheel Sodhi, Ravindra K. Gupta, P Sham, M.J. Arranz, Katherine J. Aitchison, Pak C. Sham and Christopher Monit and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Dami A. Collier

18 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dami A. Collier United Kingdom 11 308 217 180 156 147 20 749
David Herion United States 15 73 0.2× 177 0.8× 171 0.9× 107 0.7× 332 2.3× 20 1.8k
Akira Suda Japan 14 120 0.4× 234 1.1× 29 0.2× 32 0.2× 75 0.5× 46 723
Kent R. Kelley United States 9 385 1.3× 160 0.7× 152 0.8× 123 0.8× 111 0.8× 16 728
Yue Hu China 16 130 0.4× 258 1.2× 107 0.6× 71 0.5× 189 1.3× 72 947
Frederick W. Schaerf United States 9 203 0.7× 244 1.1× 30 0.2× 44 0.3× 89 0.6× 15 853
Swati Shah United States 13 58 0.2× 238 1.1× 44 0.2× 21 0.1× 204 1.4× 29 755
Joshua G. Lisinicchia United States 9 27 0.1× 152 0.7× 162 0.9× 16 0.1× 117 0.8× 13 649
Sody Munsaka Zambia 12 44 0.1× 157 0.7× 47 0.3× 17 0.1× 85 0.6× 53 669
Jennifer Kelschenbach United States 13 37 0.1× 60 0.3× 124 0.7× 17 0.1× 149 1.0× 19 555
Stephanie Restine United States 6 19 0.1× 52 0.2× 113 0.6× 51 0.3× 258 1.8× 6 491

Countries citing papers authored by Dami A. Collier

Since Specialization
Citations

This map shows the geographic impact of Dami A. Collier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dami A. Collier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dami A. Collier more than expected).

Fields of papers citing papers by Dami A. Collier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dami A. Collier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dami A. Collier. The network helps show where Dami A. Collier may publish in the future.

Co-authorship network of co-authors of Dami A. Collier

This figure shows the co-authorship network connecting the top 25 collaborators of Dami A. Collier. A scholar is included among the top collaborators of Dami A. Collier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dami A. Collier. Dami A. Collier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamelian, Kimia, Benjamín L. Sievers, M. Chen-Xu, et al.. (2025). Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression. Science Advances. 11(7). eadq3342–eadq3342.
2.
Kelly, Sophie, Sam Nightingale, Ravindra K. Gupta, & Dami A. Collier. (2025). HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives. Tropical Medicine and Infectious Disease. 10(2). 45–45. 2 indexed citations
3.
Baisley, Kathy, Joanna Orne‐Gliemann, Joseph Larmarange, et al.. (2022). Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial. HIV Medicine. 23(8). 922–928. 6 indexed citations
4.
Collier, Dami A., Isabella A.T.M. Ferreira, Rawlings Datir, et al.. (2021). Age-Related Heterogeneity in Neutralising Antibody Responses to SARS-CoV-2 Following BNT162b2 Vaccination. SSRN Electronic Journal. 6 indexed citations
5.
Kemp, Steven A., Bo Meng, Rawlings Datir, et al.. (2021). Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70. SSRN Electronic Journal. 62 indexed citations
6.
Saunders, Matthew J, Marco Tovar, Dami A. Collier, et al.. (2019). Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study. The Lancet Infectious Diseases. 19(5). 519–528. 44 indexed citations
7.
Collier, Dami A., Christopher Monit, & Ravindra K. Gupta. (2019). The Impact of HIV-1 Drug Escape on the Global Treatment Landscape. Cell Host & Microbe. 26(1). 48–60. 45 indexed citations
8.
9.
10.
Kugathasan, Ruthiran, Dami A. Collier, Lewis Haddow, et al.. (2017). Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms. Clinical Infectious Diseases. 64(8). 1059–1065. 35 indexed citations
11.
Collier, Dami A., Daniel T. Claiborne, Jessica Prince, et al.. (2016). Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency. Scientific Reports. 6(1). 38153–38153. 8 indexed citations
12.
Bouzidi, Kate El, Dami A. Collier, Eleni Nastouli, et al.. (2016). Virological efficacy of PI monotherapy for HIV-1 in clinical practice. Journal of Antimicrobial Chemotherapy. 71(11). 3228–3234. 7 indexed citations
13.
Oduyebo, Oyinlola O., et al.. (2016). Feasibility and cost analysis of programmatic implementation of microscopic-observation drug susceptibility (MODS) assay in Nigeria. Nigerian Journal of Medicine. 25(3). 226–226. 1 indexed citations
14.
15.
16.
Shaikh, Saleem, Dami A. Collier, Pak C. Sham, et al.. (1996). Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 97(6). 714–719. 118 indexed citations
17.
Arranz, M.J., Dami A. Collier, Monsheel Sodhi, et al.. (1995). Association between clozapine response and allelic variation in 5-HT2A receptor gene. The Lancet. 346(8970). 281–282. 264 indexed citations
18.
Dawson, Elisabeth, Shafaque Shaikh, Pak C. Sham, et al.. (1995). Cytochrome P4502D6 genotype does not determine response to clozapine.. British Journal of Clinical Pharmacology. 39(4). 417–420. 60 indexed citations
19.
Kerwin, R, et al.. (1994). Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors.. PubMed. 55 Suppl B. 57–62. 9 indexed citations
20.
Owen, Michael J., R. Mant, E. Parfitt, et al.. (1992). No association between RFLPs at the porphobilinogen deaminase gene and schizophrenia. Human Genetics. 90(1-2). 131–132. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Herion Breakdown of academic impact, for papers by Akira Suda Breakdown of academic impact, for papers by Kent R. Kelley Breakdown of academic impact, for papers by Yue Hu Breakdown of academic impact, for papers by Frederick W. Schaerf Breakdown of academic impact, for papers by Swati Shah Breakdown of academic impact, for papers by Joshua G. Lisinicchia Breakdown of academic impact, for papers by Sody Munsaka Breakdown of academic impact, for papers by Jennifer Kelschenbach Breakdown of academic impact, for papers by Stephanie Restine
Rankless by CCL
2026